Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,079 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Prognostic value of JAK2, MPL and CALR mutations in Chinese patients with primary myelofibrosis].
Xu ZF, Li B, Liu JQ, Li Y, Ai XF, Zhang PH, Qin TJ, Zhang Y, Wang JY, Xu JQ, Zhang HL, Fang LW, Pan LJ, Hu NB, Qu SQ, Xiao ZJ. Xu ZF, et al. Among authors: zhang hl, zhang ph, zhang y. Zhonghua Xue Ye Xue Za Zhi. 2016 Jul;37(7):576-80. doi: 10.3760/cma.j.issn.0253-2727.2016.07.007. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27535857 Free PMC article. Chinese.
[Analysis of the impact of decitabine treatment cycles on efficacy and safety in patients of myelodysplastic syndrome-refractory anemia with excess blasts].
Luo XP, Xu ZF, Qin TJ, Zhang Y, Zhang HL, Fang LW, Pan LJ, Hu NB, Qu SQ, Li B, Xiao ZJ. Luo XP, et al. Among authors: zhang hl, zhang y. Zhonghua Xue Ye Xue Za Zhi. 2016 Oct 14;37(10):870-875. doi: 10.3760/cma.j.issn.0253-2727.2016.10.011. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27801319 Free PMC article. Chinese.
[Analysis of prognostic factors in Chinese patients with post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis].
Chen M, Xu ZF, Xu JQ, Li B, Zhang PH, Qin TJ, Zhang Y, Wang JY, Zhang HL, Fang LW, Pan LJ, Hu NB, Qu SQ, Xiao ZJ. Chen M, et al. Among authors: zhang hl, zhang ph, zhang y. Zhonghua Xue Ye Xue Za Zhi. 2016 Oct 14;37(10):876-880. doi: 10.3760/cma.j.issn.0253-2727.2016.10.012. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27801320 Free PMC article. Chinese.
[A pilot study of ten-day decitabine regimen as initial therapy for newly diagnosed elderly patients with acute myeloid leukemia].
Qin TJ, Xu ZF, Zhang Y, Fang LW, Zhang HL, Pan LJ, Hu NB, Qu SQ, Li B, Xiao ZJ. Qin TJ, et al. Among authors: zhang hl, zhang y. Zhonghua Xue Ye Xue Za Zhi. 2016 Nov 14;37(11):993-995. doi: 10.3760/cma.j.issn.0253-2727.2016.11.013. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27995887 Free PMC article. Chinese. No abstract available.
[Progres of diagnosis and treatment of congenital lung malformations].
An DY, Zhang Y, Zhang HL. An DY, et al. Among authors: zhang hl, zhang y. Zhonghua Er Ke Za Zhi. 2017 Jun 2;55(6):471-474. doi: 10.3760/cma.j.issn.0578-1310.2017.06.017. Zhonghua Er Ke Za Zhi. 2017. PMID: 28592019 Chinese. No abstract available.
[The efficacy and safety of the patients of myelodysplastic syndromes-refractory anemia with excess blasts treated with decitabine alone or CAG/HAG regimen].
Xu ZF, Qin TJ, Zhang HL, Fang LW, Zhang Y, Pan LJ, Hu NB, Qu SQ, Li B, Xiao ZJ. Xu ZF, et al. Among authors: zhang hl, zhang y. Zhonghua Xue Ye Xue Za Zhi. 2017 Jul 14;38(7):572-577. doi: 10.3760/cma.j.issn.0253-2727.2017.07.004. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28810323 Free PMC article. Chinese.
2,079 results